Martindale Pharma® News Archives

Ethypharm acquires Martindale Pharma in the UK

Published 1st March 2017

The combination of the two companies will create a group with revenues of more than €300 million and a solid platform for future growth.

Clobazam oral suspension approved in seven european countries

Published 24th October 2016

Provides pan-European availability of widely used and much needed oral liquid version clobazam tablets

Martindale Pharma® announces acquisition of Viridian Pharma

Published 11th July 2016

Expands hospital-initiated medicines portfolio with a focus on neonatology and paediatrics

Martindale Pharma® announces extension of licensing agreement with Unimedic AB to include Emergency Care product portfolio

Published 30th June 2016

New agreement for sterile ampoule products in Sweden, Denmark, Norway and Finland

Martindale Pharma® announces new long term supply agreement with Burton Hospitals NHS Foundation Trust

Published 31st May 2016

Strategic and trusted supplier of essential medicines to the NHS

Martindale Pharma expands European commercial activities to include France

Published 18th May 2016

Launch of early access programme for Noyada, First novel oral liquid formulation of captopril

Prenoxad Injection approved in five European countries opening way for pan-European availability of a take-home naloxone product

Published 11th May 2016

Regulatory approval of Prenoxad Injection in Sweden, Denmark, Ireland, Finland and Estonia

Martindale Pharma announces new distribution agreement for Ireland with Fannin

Published 18th April 2016

Fannin to distribute and commercialise products within the Emergency Care, Hospital-initiated Medicines and Opioid Addiction portfolios

Martindale Pharma launches first ready-to-use presentation of Phenylephrine

Published 12th April 2016

Now available in a 10ml ampoule at a strength of 0.1mg/ml

Martindale Pharma announces major extension to partnership in Saudi Arabia and substantial new business wins

Published 4th April 2016

Sales in Middle East to grow significantly in next two years

1 2 3 4